Research Article

[Retracted] Analysis of the Efficacy of Multidrug Combination Chemotherapy Regimens for Osteosarcoma and the Management of Chemotherapeutic Reactions

Table 3

Chemotherapy reactions during chemotherapy in 21 patients with osteosarcoma (n, %).

Chemotherapy reactionsGrade
IIIIIIIVTotal

Hematotoxicity
 Leukopenia1 (4.76)5 (23.81)9 (42.86)6 (28.57)21 (100.00)
 Decreased haemoglobin2 (9.52)4 (19.05)11 (52.38)4 (19.05)21 (100.00)
 Decreased platelets1 (4.76)1 (4.76)5 (23.81)7 (33.33)14 (66.66)
Gastrointestinal reactions
 Nausea, vomiting6 (28.57)9 (42.86)3 (14.29)3 (14.29)21 (100.00)
 Oral mucositis6 (28.57)3 (14.29)4 (19.05)1 (4.76)14 (66.67)
 Gastrointestinal bleeding3 (14.29)1 (4.76)1 (4.76)0 (0.00)5 (23.81)
 Diarrhoea1 (4.76)1 (4.76)0 (0.00)0 (0.00)2 (9.52)
Hepatotoxicity
 Elevated alanine transaminase6 (28.57)8 (38.10)0 (0.00)0 (0.00)14 (66.67)
Cardiotoxicity
 Cardiac damage6 (28.57)3 (14.29)2 (9.52)0 (0.00)11 (52.38)
Nephrotoxicity
 Haematuria, proteinuria4 (19.05)1 (4.76)0 (0.00)0 (0.00)5 (23.81)
Skin toxicity
 Rash4 (19.05)2 (9.52)0 (0.00)0 (0.00)6 (28.57)
 Pigmentation2 (9.52)1 (4.76)0 (0.00)0 (0.00)3 (14.29)